Mouse models of hematopoietic engraftment

Limitations of transgenic green fluorescent protein strains and a high-performance liquid chromatography approach to analysis of erythroid chimerism

Gerald J. Spangrude, Scott Cho, Otto Guedelhoefer, Ryan C. VanWoerkom, William Fleming

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Transgenic mouse strains ubiquitously expressing green fluorescent protein (GFP) have enabled investigators to develop in vivo transplant models that can detect donor contributions to many different tissues. However, most GFP transgenics lack expression of the reporter in the erythroid lineage. We evaluated expression of GFP in the bone marrow of the OsbY01 transgenic mouse (B6-GFP) in the context of CD71 and TER-119 expression and found that GFP fluorescence is lost prior to the basophilic erythroblast stage of development. However, platelets in B6-GFP mice were found to be uniformly positive for GFP. We therefore used the GFP transgenic model in combination with allelic variants of CD45 and the hemoglobin β (Hbb) chain to develop a model system that allows all blood lineages to be followed in a mouse model of bone marrow transplantation (BMT). To detect Hbb variant molecules, we developed a new protocol based on high-performance liquid chromatography that is sensitive and precise, allowing rapid and quantitative analysis of erythroid chimerism. Platelet and leukocyte engraftment were detected by flow cytometry. BMT into sublethally irradiated (4 Gy) recipients demonstrated the failure of B6-GFP-derived cells to engraft relative to B6-CD45a-derived cells, suggesting that an immune barrier may prevent efficient engraftment of the transgenic cells in a setting of minimal ablation. These results establish limitations in the use of transgenic GFP expression as a donor marker in transplantation models.

Original languageEnglish (US)
Pages (from-to)2045-2051
Number of pages7
JournalStem Cells
Volume24
Issue number9
DOIs
StatePublished - 2006

Fingerprint

Chimerism
Green Fluorescent Proteins
High Pressure Liquid Chromatography
Bone Marrow Transplantation
Transgenic Mice
Blood Platelets
Erythroblasts
Flow Cytometry
Hemoglobins
Leukocytes
Transplantation
Fluorescence
Bone Marrow
Research Personnel
Transplants

Keywords

  • Engraftment
  • Erythropoiesis
  • Hematopoietic cell transplantation
  • Hematopoietic chimerism

ASJC Scopus subject areas

  • Cell Biology

Cite this

Mouse models of hematopoietic engraftment : Limitations of transgenic green fluorescent protein strains and a high-performance liquid chromatography approach to analysis of erythroid chimerism. / Spangrude, Gerald J.; Cho, Scott; Guedelhoefer, Otto; VanWoerkom, Ryan C.; Fleming, William.

In: Stem Cells, Vol. 24, No. 9, 2006, p. 2045-2051.

Research output: Contribution to journalArticle

@article{47e635b33a0b4d539cff5eb399a6729d,
title = "Mouse models of hematopoietic engraftment: Limitations of transgenic green fluorescent protein strains and a high-performance liquid chromatography approach to analysis of erythroid chimerism",
abstract = "Transgenic mouse strains ubiquitously expressing green fluorescent protein (GFP) have enabled investigators to develop in vivo transplant models that can detect donor contributions to many different tissues. However, most GFP transgenics lack expression of the reporter in the erythroid lineage. We evaluated expression of GFP in the bone marrow of the OsbY01 transgenic mouse (B6-GFP) in the context of CD71 and TER-119 expression and found that GFP fluorescence is lost prior to the basophilic erythroblast stage of development. However, platelets in B6-GFP mice were found to be uniformly positive for GFP. We therefore used the GFP transgenic model in combination with allelic variants of CD45 and the hemoglobin β (Hbb) chain to develop a model system that allows all blood lineages to be followed in a mouse model of bone marrow transplantation (BMT). To detect Hbb variant molecules, we developed a new protocol based on high-performance liquid chromatography that is sensitive and precise, allowing rapid and quantitative analysis of erythroid chimerism. Platelet and leukocyte engraftment were detected by flow cytometry. BMT into sublethally irradiated (4 Gy) recipients demonstrated the failure of B6-GFP-derived cells to engraft relative to B6-CD45a-derived cells, suggesting that an immune barrier may prevent efficient engraftment of the transgenic cells in a setting of minimal ablation. These results establish limitations in the use of transgenic GFP expression as a donor marker in transplantation models.",
keywords = "Engraftment, Erythropoiesis, Hematopoietic cell transplantation, Hematopoietic chimerism",
author = "Spangrude, {Gerald J.} and Scott Cho and Otto Guedelhoefer and VanWoerkom, {Ryan C.} and William Fleming",
year = "2006",
doi = "10.1634/stemcells.2006-0013",
language = "English (US)",
volume = "24",
pages = "2045--2051",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "9",

}

TY - JOUR

T1 - Mouse models of hematopoietic engraftment

T2 - Limitations of transgenic green fluorescent protein strains and a high-performance liquid chromatography approach to analysis of erythroid chimerism

AU - Spangrude, Gerald J.

AU - Cho, Scott

AU - Guedelhoefer, Otto

AU - VanWoerkom, Ryan C.

AU - Fleming, William

PY - 2006

Y1 - 2006

N2 - Transgenic mouse strains ubiquitously expressing green fluorescent protein (GFP) have enabled investigators to develop in vivo transplant models that can detect donor contributions to many different tissues. However, most GFP transgenics lack expression of the reporter in the erythroid lineage. We evaluated expression of GFP in the bone marrow of the OsbY01 transgenic mouse (B6-GFP) in the context of CD71 and TER-119 expression and found that GFP fluorescence is lost prior to the basophilic erythroblast stage of development. However, platelets in B6-GFP mice were found to be uniformly positive for GFP. We therefore used the GFP transgenic model in combination with allelic variants of CD45 and the hemoglobin β (Hbb) chain to develop a model system that allows all blood lineages to be followed in a mouse model of bone marrow transplantation (BMT). To detect Hbb variant molecules, we developed a new protocol based on high-performance liquid chromatography that is sensitive and precise, allowing rapid and quantitative analysis of erythroid chimerism. Platelet and leukocyte engraftment were detected by flow cytometry. BMT into sublethally irradiated (4 Gy) recipients demonstrated the failure of B6-GFP-derived cells to engraft relative to B6-CD45a-derived cells, suggesting that an immune barrier may prevent efficient engraftment of the transgenic cells in a setting of minimal ablation. These results establish limitations in the use of transgenic GFP expression as a donor marker in transplantation models.

AB - Transgenic mouse strains ubiquitously expressing green fluorescent protein (GFP) have enabled investigators to develop in vivo transplant models that can detect donor contributions to many different tissues. However, most GFP transgenics lack expression of the reporter in the erythroid lineage. We evaluated expression of GFP in the bone marrow of the OsbY01 transgenic mouse (B6-GFP) in the context of CD71 and TER-119 expression and found that GFP fluorescence is lost prior to the basophilic erythroblast stage of development. However, platelets in B6-GFP mice were found to be uniformly positive for GFP. We therefore used the GFP transgenic model in combination with allelic variants of CD45 and the hemoglobin β (Hbb) chain to develop a model system that allows all blood lineages to be followed in a mouse model of bone marrow transplantation (BMT). To detect Hbb variant molecules, we developed a new protocol based on high-performance liquid chromatography that is sensitive and precise, allowing rapid and quantitative analysis of erythroid chimerism. Platelet and leukocyte engraftment were detected by flow cytometry. BMT into sublethally irradiated (4 Gy) recipients demonstrated the failure of B6-GFP-derived cells to engraft relative to B6-CD45a-derived cells, suggesting that an immune barrier may prevent efficient engraftment of the transgenic cells in a setting of minimal ablation. These results establish limitations in the use of transgenic GFP expression as a donor marker in transplantation models.

KW - Engraftment

KW - Erythropoiesis

KW - Hematopoietic cell transplantation

KW - Hematopoietic chimerism

UR - http://www.scopus.com/inward/record.url?scp=33749166961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749166961&partnerID=8YFLogxK

U2 - 10.1634/stemcells.2006-0013

DO - 10.1634/stemcells.2006-0013

M3 - Article

VL - 24

SP - 2045

EP - 2051

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 9

ER -